Messenger RNA turnover during bone marrow erythroid cell differentiation.

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Bone marrow cells synthesize various proteins, including globin, essential for red blood cell function.
• Differential stability of messenger RNA (mRNA) species influences protein synthesis regulation.

Purpose of the Study:

• To investigate the differential stability of globin mRNA compared to other bone marrow cell mRNAs.
• To explore the mechanisms underlying selective mRNA degradation in erythropoiesis.

Main Methods:

• Incubation of rabbit bone marrow cells with actinomycin D.
• In vivo and in vitro protein synthesis labeling.
• RNA isolation and in vitro translation.
• Pulse-labeling of RNA and separation using cDNA-oligo(dT)-cellulose chromatography.
• Treatment with RNA synthesis inhibitors (actinomycin D, alpha-amanitin) and a lysosomal inhibitor (chloroquine).

Main Results:

• Actinomycin D treatment increased the relative synthesis of globin, indicating enhanced globin mRNA stability.
• Globin mRNA levels rose significantly while other poly(A)-rich RNA decreased after pulse-labeling.
• Early erythropoietic cells showed increased susceptibility to RNA synthesis inhibitors.
• Preliminary data suggested both lysosomal and non-lysosomal pathways for mRNA degradation.

Conclusions:

• Globin mRNA exhibits significantly greater metabolic stability than other bone marrow cell mRNAs.
• Differential mRNA stability is a key regulatory mechanism in erythropoiesis.
• Multiple cellular pathways contribute to selective mRNA degradation.